Galenica S.A.

Galenica is one of the largest Greek pharmaceutical companies which promotes research and serves health with consistency and scientific responsibility, by developing high-quality and innovative pharmaceutical products.


Read more:

Nicolas Adamopoulos, New Business Development Manager

"Galenica is facing the challenge of a sustainable future"

Galenica is facing the challenge of a sustainable future by integrating and promoting the principles of sustainable development and corporate responsibility in its operation:

•We operate according to international standards and regulations (GMPs, GLPs and ISO 9001: 2000, ISO PROTECTED: 2004). We implement production processes with emphasis on recycling, conservation of natural resources and proper waste management.

•We invest in Research and Development in collaboration with prestigious University Research Centers.

•We support the life-long education of our employees through internal specified seminars, training and post-graduate programs as a major management responsibility action towards our people, and the continuing education of health professionals by organizing high-level scientific meetings in cooperation with scientific bodies of Greece and abroad.

•We promote and support the rules of transparency and business ethics by applying the Code of Ethics EFPIA (European Federation of Pharmaceutical Industries and Associations) interdepartmentally to all the functions of our company.

•We support the Medical Association of Athens, Municipalities and NGOs, through donations of drugs independently as well as through our Collective Bodies, helping to improve the quality of life of our fellow citizens.

•We participate in voluntary activities, indicatively mentioning the voluntary blood donation as part of our social contribution.

•We support the release of special editions with scientific, historical and cultural interest, classified as bibliographical references.

Nicolas Adamopoulos, New Business Development Manager


Responsible Entrepreneurship